Chronotropic, dromotropic and inotropic effects of dilazep in the intact dog heart and isolated atrial preparation. 1984

S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa

When dilazep was administered intravenously to the anesthetized donor dog, mean systemic blood pressure was dose dependently decreased. At a dose of 0.1 mg/Kg i.v., the mean blood pressure was not changed but a slight decrease in heart rate was usually observed in the donor dog. At the same time, a slight but significant decrease in atrial rate and developed tension of the isolated atrium was induced. Within a dose range of 0.3 to 1 mg/Kg i.v., dilazep caused a dose related decrease in mean blood pressure, bradycardia in the donor dog, and negative chronotropic, dromotropic and inotropic effects in the isolated atrium. At larger doses of 3 and 10 mg/Kg i.v., dilazep caused marked hypotension, frequently with severe sinus bradycardia or sinus arrest, especially in isolated atria. When dilazep was infused intraarterially at a rate of 0.2-1 micrograms/min into the cannulated sinus node artery of the isolated atrium, negative chrono- and inotropic effects were dose dependently induced. With respect to dromotropism, SA conduction time (SACT) was prolonged at infusion rates of 0.2 and 0.4 micrograms/min. But at 1 microgram, dilazep caused an increase or decrease of SACT, indicating a shift of the SA nodal pacemaker. It is concluded that dilazep has direct negative chrono-, dromo- and inotropic properties on the heart at doses which produced no significant hypotension.

UI MeSH Term Description Entries
D008297 Male Males
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009529 Nicardipine A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. Antagonil,Cardene,Cardene I.V.,Cardene SR,Dagan,Flusemide,Lecibral,Lincil,Loxen,Lucenfal,Nicardipine Hydrochloride,Nicardipine LA,Nicardipino Ratiopharm,Nicardipino Seid,Perdipine,Ridene,Vasonase,Y-93,Hydrochloride, Nicardipine,LA, Nicardipine,Y 93,Y93
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D010313 Partial Pressure The pressure that would be exerted by one component of a mixture of gases if it were present alone in a container. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Partial Pressures,Pressure, Partial,Pressures, Partial
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004109 Dilazep Coronary vasodilator with some antiarrhythmic activity. Asta C 4898,Biopropazepan Trimethoxybenzoate,Cormelian,C 4898, Asta,Trimethoxybenzoate, Biopropazepan
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006325 Heart Atria The chambers of the heart, to which the BLOOD returns from the circulation. Heart Atrium,Left Atrium,Right Atrium,Atria, Heart,Atrium, Heart,Atrium, Left,Atrium, Right

Related Publications

S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
September 2000, American journal of physiology. Heart and circulatory physiology,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
April 1987, Journal of cardiovascular pharmacology,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
January 1982, Acta medica Scandinavica. Supplementum,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
April 1971, The Journal of physiology,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
January 1989, Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
May 1968, The Journal of physiology,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
May 1979, Chest,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
July 1976, European journal of pharmacology,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
December 1996, Journal of the autonomic nervous system,
S Chiba, and M Kobayashi, and M Shimotori, and Y Furukawa, and K Saegusa
January 1992, Heart and vessels,
Copied contents to your clipboard!